
<!DOCTYPE html>
<html lang="en">
<head>
<!-- Meta-Tag -->
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">

<title>TolsuraHCP</title>

<meta name="apple-mobile-web-app-status-bar-style" content="#cd9f26">
<meta name="theme-color" content="#cd9f26" />

<!-- googlefont -->
<link rel="preconnect" href="https://fonts.gstatic.com">
<link href="https://fonts.googleapis.com/css2?family=Source+Sans+Pro:ital,wght@0,400;0,600;0,700;1,400;1,600;1,700&display=swap" rel="stylesheet">

<!-- favicon -->
<link rel="icon" href="assets/img/favicon.ico">

<!-- CSS -->
<link rel="stylesheet" href="assets/css/bootstrap.min.css">
<link rel="stylesheet" href="assets/css/style.css">
</head>
<body>
<!-- Announcement Bar Start -->
<div class="announcement__bar text-center text-white pt-lg-3 pb-lg-3 pt-2 pb-2">
    <div class="container">
        <div class="d-flex justify-content-center align-items-center">
            <div class="announcement__title"><strong>JOIN US FOR A SPECIAL WEBINAR</strong> ABOUT OUR BREAKTHROUGH ANTIFUNGAL INNOVATION, TOLSURA</div>
            <a href="#" class="btn btn-transparent"><span class="d-none d-lg-block">REGISTER TO JOIN</span><img class="d-block d-lg-none" src="assets/img/icons-arrow_right.svg" alt="Icons Arrow Right"> </a>
        </div>
    </div>
</div>
<!-- Announcement Bar End -->

<!-- HEADER START -->
<header>
    <div class="container">
        <div class="d-flex align-items-center">
            <a class="nav__toggle" href="#" aria-label="Toggle navigation"><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span></a>
            <a href="index.html" class="logo"><img src="assets/img/TOLSURA_DARK_LOGO.png" alt="Go To Tolsura"></a>
            <div class="nav__block flex-column">
                <div class="nav-wrapper d-flex flex-lg-column-reverse">
                    <div class="primary__nav">
                        <ul>
                            <li class="menu-item menu-item-type-post_type menu-item-object-page"><a href="infection-overview.html">INFECTIONS OVERVIEW</a></li>
                            <li class="menu-item menu-item-type-post_type menu-item-object-page"><a href="#">ABOUT TOLSURA</a></li>
                            <li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children current-menu-item current_page_item"><a href="#">BENEFITS OF TOLSURA</a>
                                <ul>
                                    <li class="menu-item menu-item-type-post_type menu-item-object-page"><a href="bioavailability.html">BIOAVAILABILITY</a></li>
                                    <li class="menu-item menu-item-type-post_type menu-item-object-page"><a href="absorption.html">ABSORPTION</a></li>
                                    <li class="menu-item menu-item-type-post_type menu-item-object-page current-menu-item current_page_item"><a href="#">THERAPEUTIC LEVELS</a></li>
                                </ul>
                            </li>
                            <li class="menu-item menu-item-type-post_type menu-item-object-page"><a href="safety.html">SAFETY</a></li>
                            <li class="menu-item menu-item-type-post_type menu-item-object-page"><a href="dosing.html">DOSING</a></li>
                            <li class="menu-item menu-item-type-post_type menu-item-object-page"><a href="savings.html">SAVINGS</a></li>
                        </ul>
                    </div>
                    <div class="secondary__nav mb-md-3">
                        <ul>
                            <li class="menu-item menu-item-type-post_type menu-item-object-page"><a href="#isi-expand">Important Safety Information</a></li>
                            <li class="menu-item menu-item-type-post_type menu-item-object-page"><a href="#">Prescribing Information</a></li>
                            <li class="menu-item menu-item-type-post_type menu-item-object-page"><a href="#">Patient Site</a></li>
                        </ul>
                    </div>
                </div>
            </div>
            <div class="ml-auto">
                <a class="btn" data-toggle="modal" data-target="#myModal">Contact A Representative</a>
            </div> 
        </div>
    </div>
</header>
<!-- HEADER END -->

<!-- BANNER SECTION START -->
<section class="page__banner" style="background-image: url(assets/img/Therapeutic_levels_triangle_graphic.png);">
    <div class="container">
        <div class="page__banner-description">
            <h1><strong>81% of Subjects Treated with TOLSURA</strong> Achieved Therapeutic Blood Levels</h1>
        </div>
    </div>
</section>
<!-- BANNER SECTION END -->

<!-- skip to content link start -->
<a class="sr-only skip-link screen-reader-text" href="#maincontent">Skip to the content</a>
<!-- skip to content link end -->

<!-- PAGE CONTENT START -->
<main id="maincontent" class="pagecontent">

    <!-- TOLSURA PATIENT TREATMENT -->
    <div class="treatment__col pt-100 pb-5">
        <div class="primary__title">
            <div class="container">
                <div class="row">
                    <div class="col-xl-10 col-lg-10">
                        <h2>THE MAJORITY OF TOLSURA 65 MG SUBJECTS ACHIEVED THERAPEUTIC LEVELS VS. CONVENTIONAL ITRACONAZOLE PATIENTS<sup>1</sup></h2>
                    </div>
                </div>
            </div>
        </div>
        <div class="container">
            <div class="row pl-100">
                <div class="col-md-6">
                    <div class="treatment__col--block text-center gray__bg">
                        <p><span class="green-color">84%</span> more TOLSURA subjects achieved therapeutic levels vs. subjects on SPORANOX® 100 mg (81% vs 44%)<sup>1</sup></p>
                    </div>
                </div>
                <div class="col-md-6">
                    <div class="treatment__col--block text-center gray__bg">
                        <p><span class="green-color">TOTAL AND PEAK ITRACONAZOLE EXPOSURE</span> was similar between TOLSURA (65 mg) and SPORANOX (100 mg) treatments<sup>1</sup></p>
                    </div>
                </div>
                <div class="col-md-6">
                    <div class="treatment__col--block text-center gray__bg">
                        <p><span class="green-color">~2X GREATER RELATIVE BIOAVAILABILITY</span> vs. conventional itraconazole when C<sub>trough</sub> was corrected for dose administration in a fed state<sup>2</sup></p>
                    </div>
                </div>
                <div class="col-md-6">
                    <div class="treatment__col--block text-center gray__bg">
                        <p><span class="green-color">STEADY STATE CONCENTRATIONS</span> reached within 15 days<sup>3</sup></p>
                    </div>
                </div>
            </div>
        </div>
        <div class="patient__variability text-center" style="background-image: url(assets/img/senior-farmer_image.png);">
            <div class="container">
                <h2>TOLSURA CAN <strong>REDUCE PATIENT VARIABILITY</strong> AND PRODUCE POTENTIALLY PREDICTABLE RESULTS<sup>1</sup></h2>
            </div>
        </div>
    </div>

    <!-- PERCENTAGE OF SUBJECTS SECTION START -->
    <div class="tolsura__chart pt-100 pb-100">
        <div class="container">
            <div class="row">
                <div class="col-xl-8 col-lg-9 mb-lg-5">
                    <h2>PERCENTAGE OF SUBJECTS WHO REACHED C<sub>trough</sub> LEVEL AT 1,034 ng/ml AT STEADY-STATE</h2>
                    <p>In systemic therapy, itraconazole serum trough levels below 1,000 ng/ml are predictive of therapeutic failure</p>
                </div>
                <div class="col-lg-12 mt-5">
                    <img class="img-fluid w-100" src="assets/img/Cthrough-level-graph.png" alt="Percentage Of Subjects">
                </div>
            </div>
        </div>
    </div>
    <!-- PERCENTAGE OF SUBJECTS SECTION END -->

    <!-- THERAPEUTIC FASTED CONDITION START -->
    <div class="section pt-100 pb-100">
        <div class="primary__title">
            <div class="container">
                <div class="row">
                    <div class="col-xl-10 col-lg-10">
                     <h2>THERAPEUTIC LEVELS ARE ACHIEVED AND MAINTAINED WITH TOLSURA 65 MG CAPSULES IN BOTH FED AND FASTED CONDITIONS<sup>4</sup></h2>
                    </div>
                </div>
            </div>
        </div>
        <div class="food__requirements">
            <div class="container">
                <div class="row mt-5">
                    <div class="col-md-6">
                        <div class="article__block position-relative mb-5">
                            <img src="assets/img/Triangle_1.svg" alt="Traingle">
                            <p>Peak plasma concentrations of itraconazole after a single dose of TOLSURA are reached after 2 – 6 hours in both fasted and fed states<sup>3</sup></p>
                        </div>
                        <div class="article__block position-relative mb-5">
                            <img src="assets/img/Triangle_1.svg" alt="Traingle">
                            <p>Bioavailability of conventional itraconazole capsules is reduced by 40% when taken with food<sup>5†</sup></p>
                            <div class="d-block small">†capsule formulation</div>
                        </div>
                        <div class="article__block position-relative mb-5">
                            <img src="assets/img/Triangle_1.svg" alt="Traingle">
                            <p>Serum concentrations below 1,000 ng/ml are predictive of therapeutic failure<sup>4</sup></p>
                        </div>
                    </div>
                    <div class="col-md-6">
                        <div class="mid-left-gray-box">
                            <div class="mid-inner-box-content">
                            <img src="assets/img/food_drink.svg" alt="food-drink">
                            <p><strong>THE FDA LABEL REQUIRES ADMINISTRATION WITH FOOD.</strong></p>
                            <p>Conventional itraconazole capsules must be taken with a full meal and, in certain cases, a can of a non-diet cola</p>
                            </div>
                        </div>
                    </div>
                </div>
                <div class="row pt-100 pb-100 fasted__food">
                    <div class="col-md-6">
                    <div class="food-box">
                        <div class="red-food-box">
                            <img class="img-fluid" src="assets/img/eat-icon.svg" alt="eat icon">
                            <span class="icon-text">
                                <img class="img-fluid" src="assets/img/Graph-line_red.svg" alt="graph line red"><br>
                                FED
                            </span>
                            <div class="red-eat-text">
                                <p>TOLSURA <br>2x 65 mg capsules</p>
                            </div>
                        </div>
                    </div>
                    </div>
                    <div class="col-md-6">
                    <div class="food-box green-color">
                        <div class="red-food-box">
                            <img class="img-fluid" src="assets/img/fasted-icon.svg" alt="fasted icon">
                            <span class="icon-text">
                                <img class="img-fluid" src="assets/img/graph_line_green.png" alt="graph line green"><br>
                                FASTED
                            </span>
                            <div class="red-eat-text">
                                <p>TOLSURA <br>2x 65 mg capsules</p>
                            </div>
                        </div>
                    </div>
                    </div>
                </div>
                <div class="medicine__graph">
                    <img src="assets/img/fed-fasted-graph.png" alt="Fed Fasted Graph" class="img-fluid">
                </div>
            </div>
        </div>
    </div>
    <!-- THERAPEUTIC FASTED CONDITION END -->

    <!-- SUBA SCIENCE SECTION START -->
    <div class="section suba-science green__bg">
        <img class="traingle-marker img-fluid" src="assets/img/triangle.svg" alt="Traingle Marker">
        <div class="container">
            <div class="d-flex justify-content-lg-between align-items-center flex-lg-row flex-column text-white">
                <h2>THE SCIENCE OF SUBA®</h2>
                <a class="watch-video position-relative" href="#" data-toggle="modal" data-target="#myVideo">
                    <img src="assets/img/Triangle-white.svg" alt="Watch Video"> WATCH MECHANISM OF ACTION VIDEO
                </a>
            </div>
        </div>
    </div>
    <div class="section suba-cta" style="background-image: url(assets/img/suba-cta.png);"></div>
    <div class="modal" id="myVideo">
        <div class="modal-dialog video modal-dialog-centered">
        <div class="modal-content">
            <button type="button" class="close" data-dismiss="modal"><img src="assets/img/Icons_close-white.svg" alt="close"></button>
            <div class="modal-body">
                <script src="https://fast.wistia.com/embed/medias/jqf8u63qgs.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_jqf8u63qgs videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/jqf8u63qgs/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" aria-hidden="true" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
            </div>
        </div>
        </div>
    </div>
   <!-- SUBA SCIENCE SECTION END -->

  <!-- Contact Modal -->
  <div class="modal" id="myModal">
    <div class="modal-dialog modal-lg">
      <div class="modal-content p-4">
        <!-- Modal Header -->
        <div class="modal-header">
          <button type="button" class="close" data-dismiss="modal"><img src="assets/img/Icons_close.svg" alt="close"></button>
          <div class="form-title" id="form-title">
             INTERESTED IN STARTING YOUR JOURNEY WITH TOLSURA?
             <span class="form-sub-title">
                Sign up for an introductory conversation with one of our representatives
             </span>
          </div>
        </div>
        
        <!-- Modal body -->
        <div class="modal-body">
           <form id="contact-form-popup" method="post">
             <div class="container">
                <div class="row">
                   <div class="col-md-6">
                      <div class="form-group">
                         <label for="firstname">First and Last Name*</label>
                         <input type="text" class="form-control" id="firstname" name="firstname" required="required">
                       </div>
                   </div>
                   <div class="col-md-6">
                      <div class="form-group">
                         <label for="phone">Phone*</label>
                         <input type="text" pattern="[0-9]{1}[0-9]{9}" class="form-control" id="phone"  name="phone" required="required">
                       </div>
                   </div>
                   <div class="col-md-6">
                      <div class="form-group">
                         <label for="jobtitle">Job Title*</label>
                         <div class="controlselect">
                             <select name="jobtitle" id="jobtitle" class="form-control" required="required">
                                 <option value="" selected disabled>Please select</option>
                                 <option value="Doctor of Medicine">Doctor of Medicine</option>
                                 <option value="Doctor of Osteopathy">Doctor of Osteopathy</option>
                                 <option value="Nurse Practitioner">Nurse Practitioner</option>
                                 <option value="Physician Assistant">Physician Assistant</option>
                                 <option value="Medical Assistant">Medical Assistant</option>
                                 <option value="Admin">Admin</option>
                                 <option value="Other">Other</option>
                             </select>
                         </div>
                       </div>
                   </div>
                   <div class="col-md-6">
                      <div class="form-group">
                         <label for="address">Address*</label>
                         <input type="text" class="form-control" id="address"  name="address" required="required">
                       </div>
                   </div>
                   <div class="col-md-6">
                      <div class="form-group">
                         <label for="specialty">Specialty*</label>
                         <div class="controlselect">
                             <select name="specialty" id="specialty" class="form-control" required="required">
                               <option value="" selected disabled>Please select</option>
                               <option value="Infectious Disease">Infectious Disease</option>
                               <option value="Pulmonary Disease">Pulmonary Disease</option>
                               <option value="Internal Medicine">Internal Medicine</option>
                               <option value="Family Medicine">Family Medicine</option>
                               <option value="Hematology/Oncology">Hematology/Oncology</option>
                               <option value="Other">Other</option>
                             </select>
                         </div>
                       </div>
                   </div>
                   <div class="col-md-6">
                      <div class="form-group">
                         <label for="city">City*</label>
                         <input type="text" class="form-control" id="city"  name="city" required="required">
                       </div>
                   </div>
                   <div class="col-md-6">
                      <div class="form-group">
                         <label for="email">Email*</label>
                         <input type="email" class="form-control" id="email"  name="email" required="required">
                       </div>
                   </div>
                   <div class="col-md-6">
                      <div class="row">
                         <div class="col-md-6">
                            <div class="form-group">
                               <label for="zip">ZIP*</label>
                               <input type="text" class="form-control" id="zip"  name="zip" required="required">
                             </div>
                         </div>
                         <div class="col-md-6">
                            <div class="form-group">
                               <label for="state">State*</label>
                               <div class="controlselect">
                                 <select name="state" id="state" class="form-control" required="required">
                                     <option value="" selected disabled>Please select</option>
                                       <option value="CA">California</option>
                                       <option value="CO">Colorado</option>
                                       <option value="CT">Connecticut</option>
                                       <option value="DC">Washington DC</option>
                                       <option value="DE">Delaware</option>
                                       <option value="FL">Florida</option>
                                       <option value="GA">Georgia</option>
                                       <option value="IA">Iowa</option>
                                       <option value="ID">Idaho</option>
                                       <option value="IL">Illinois</option>
                                       <option value="IN">Indiana</option>
                                       <option value="KS">Kansas</option>
                                       <option value="KY">Kentucky</option>
                                       <option value="LA">Louisiana</option>
                                       <option value="MA">Massachusetts</option>
                                       <option value="MD">Maryland</option>
                                       <option value="ME">Maine</option>
                                       <option value="MI">Michigan</option>
                                       <option value="MN">Minnesota</option>
                                       <option value="MO">Missouri</option>
                                       <option value="MS">Mississippi</option>
                                       <option value="MT">Montana</option>
                                       <option value="NC">North Carolina</option>
                                       <option value="ND">North Dakota</option>
                                       <option value="NE">Nebraska</option>
                                       <option value="NH">New Hampshire</option>
                                       <option value="NJ">New Jersey</option>
                                       <option value="NM">New Mexico</option>
                                       <option value="NV">Nevada</option>
                                       <option value="NY">New York</option>
                                       <option value="OH">Ohio</option>
                                       <option value="OK">Oklahoma</option>
                                       <option value="OR">Oregon</option>
                                       <option value="PA">Pennsylvania</option>
                                       <option value="RI">Rhode Island</option>
                                       <option value="SC">South Carolina</option>
                                       <option value="SD">South Dakota</option>
                                       <option value="TN">Tennessee</option>
                                       <option value="TX">Texas</option>
                                       <option value="UT">Utah</option>
                                       <option value="VA">Virginia</option>
                                       <option value="VT">Vermont</option>
                                       <option value="WA">Washington</option>
                                       <option value="WI">Wisconsin</option>
                                       <option value="WV">West Virginia</option>
                                       <option value="WY">Wyoming</option> 
                                     </select>
                               </div>
                             </div>
                         </div>
                      </div>
                      
                   </div>
                </div>
                <div class="row mt-4">
                   <div class="col-md-4 btn-warning-popup">
                      <img src="https://awareness.tolsura.com/l/153741/2021-01-20/43dkgf/153741/16111229975pdGm9Jm/warning_icon.svg" alt="warning"> This is a required field.
                   </div>
                   
                   <div class="col-md-8  text-right">
                      <span class="btn-info-popup">By clicking ‘Send' you agree to be contacted by phone by a sales representative of Mayne Pharma</span>
                      <button class="btn green-btn" onclick="formSubmit()">SEND NOW</button>
                   </div>
                </div>
             </div>
            </form>
            <!--For Thank you Part-->
            <div class="thank-you-popup text-center " id="thankyouPage">
                <div class="thank-you-msg" id="tymsg">
                    <div class="heading red-color mb-5">Thank You</div>
                    <div class="pt-4">One of our representatives will <br /> get in touch with you soon.</div>
                </div>
            </div>
        </div>
      </div>
    </div>
  </div>
</main>
<!-- PAGE CONTENT END -->

<!-- ISI BLOCK START -->
<div id="isi-expand" class="section pt-100">
    <div class="container pb-100">
        <div class="row">            
            <div class="col-md-12">
                <p>Indications and Important <br class="d-block d-lg-none d-md-none">  Safety Information  </p>
                <div class="warning-box">
                <p class="mb-0"><strong>BOXED WARNING</strong> <br /><strong>WARNING: CONGESTIVE HEART FAILURE and DRUG INTERACTIONS</strong></p>
                <ul class="bullet1 mb-1 mt-1">
                <li>» CONGESTIVE HEART FAILURE</li>
                </ul>
                <p class="mb-1 pl-3"><strong>TOLSURA can cause or exacerbate congestive heart failure (CHF). When itraconazole was administered intravenously to healthy human volunteers and dogs, negative inotropic effects were seen. </strong>If signs or symptoms of congestive heart failure occur or worsen during administration of TOLSURA, reassess the benefit and risk of continuing treatment.</p>
                <ul class="bullet1">
                    <li> » DRUG INTERACTIONS</li>
                </ul>
                <ul class="bullet2">
                    <li>Co-administration of certain drugs that are metabolized by human CYP3A4 enzymes are contraindicated with
                    TOLSURA because plasma concentrations of such drugs are increased, which may also increase or prolong both the
                    pharmacologic effects and/or adverse reactions to these drugs.</li>
                    <li>Co-administration with colchicine, fesoterodine and solifenacin is contraindicated in subjects with varying degrees of renal or hepatic impairment, and</li>
                    <li>Co-administration with eligustat is contraindicated in subjects taking strong or moderate CYP2D6 inhibitors. </li>
                    <li>Increased plasma concentrations of some of these drugs caused by co-administration with TOLSURA can lead to QT prolongation and/or ventricular tachyarrhythmias, including occurrences of torsades de pointes, a potentially fatal arrhythmia.</li>
                </ul>
            </div>
        </div>
        <div class="col-md-12">
            <p class="mb-0"><strong>Indications and Usage</strong> </p>
            <p>TOLSURA is an azole antifungal indicated for the treatment of the following fungal infections in <strong>immunocompromised and non-immunocompromised</strong> adult patients:</p>
            <ul class="bullet2 ml-2">
                <li>Blastomycosis, pulmonary and extrapulmonary</li>
                <li>Histoplasmosis, including chronic cavitary pulmonary disease and disseminated, non-meningeal histoplasmosis, and</li>
                <li>Aspergillosis, pulmonary and extrapulmonary, in patients who are intolerant of or who are refractory to amphotericin B therapy </li>
            </ul>
            <p class="mb-0 mb-2 mt-4"><strong>Limitations of Use:</strong></p>
            <p class="mb-0">TOLSURA is not indicated for the treatment of onychomycosis.</p>
            <p class="mb-0">TOLSURA is NOT interchangeable or substitutable with other itraconazole products.</p>
            <p class="mb-0 mb-2 mt-4"><strong>Contraindications</strong></p>
            <p class="mb-0">Co-administration with certain drugs that either affect metabolism of itraconazole or whose metabolism is affected by itraconazole Hypersensitivity to itraconazole</p>
            <p class="mb-0 mb-2 mt-4"><strong>Warnings and Precautions</strong></p>
            <ul class="bullet2 ml-2">
                <li><strong>Hepatotoxicity:</strong> Serious hepatotoxicity, including liver failure and death, were reported with the use of itraconazole. Discontinue treatment if signs of liver dysfunction occur</li>
                <li><strong>Cardiac Dysrhythmias:</strong> Life-threatening cardiac dysrhythmias and/or sudden death have occurred in patients using certain drugs that are metabolized by human CYP450 enzymes concomitantly with oral itraconazole and/or other CYP3A4 inhibitors.</li>
                <li><strong>Peripheral Neuropathy:</strong> This has been reported in patients on long-term therapy with itraconazole. Monitor and promptly evaluate neurologic symptoms </li>
                <li><strong>Hearing loss:</strong> Reversible or permanent hearing loss has been reported in patients. Discontinue treatment if hearing loss occurs </li>
            </ul>
            <p class="mb-0 mb-2 mt-4"><strong>Adverse Reactions</strong></p>
            <p class="mb-4">Most common adverse reactions (incidence ≥ 1%) are nausea, rash, vomiting, edema, headache, diarrhea, fatigue, fever, pruritus, hypertension, abnormal hepatic function, abdominal pain, dizziness, hypokalemia, anorexia, malaise, decreased libido, somnolence, albuminuria, and impotence.</p>
            <p class="mb-4"><strong>To report SUSPECTED ADVERSE REACTIONS, contact Mayne Pharma at <a href="tel:+18448258500">1-844-825-8500</a> or the FDA at 1-800-FDA-1088 or <a target="_blank" href="https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program"><u>www.fda.gov/medwatch.</u></a></strong></p>
            <p class="mb-0"><strong>For more information, please see full <a class="underline" target="_blank" href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=306352d1-9d5a-49ad-b72d-893b99546861&audience=professional"><u>Prescribing Information and Patient Information Leaflet.</u> </a></strong></p>
        </div>
    </div>
    </div>
    <!-- REFERENCE SECTION START -->
    <div class="section pt-100 pb-100">
        <div class="container">
            <div class="references-block">
                <h2>References:</h2>
                <ul>
                    <li>Mudge S, Burnett BP. Pharmacokinetic Analysis of SUBA™-itraconazole Capsules Compared to <br>Conventional Itraconazole Capsules for a 3-Day Loading Dose Regimen and After 15 Days of<br> Administration. Poster presented (#L0043) at 29th European Congress of Clinical Mi¬crobiology & <br>Infectious Diseases, Amsterdam, Netherlands. April 13-16, 2019.</li>              
                    <li>Data on File. Mayne Pharma, Inc. 2017.</li>
                    <li>TOLSURA® Product Information. Mayne Pharma. Greenville, NC. 12/2018.</li>
                    <li>Lindsay J, et al. Antimicrob Agents Chemother. 2018;62(12)e01723-18.</li>
                    <li>Barone JA, et al. Antimicrob Agents Chemother. 1993;37(4):778-784.</li>
                </ul>
            </div>
        </div>
    </div>
</div>
<!-- REFERENCE SECTION START -->
    
<div id="isi" class="section">
    <div class="container pb-100">
        <p>Indications and Important <br class="d-block d-lg-none d-md-none">  Safety Information 
        <span class="expand-collapse-isi">
            <a href="#"><img class="fa fa-plus expand-isi" src="https://awareness.tolsura.com/l/153741/2021-04-12/442dl8/153741/1618221207YVr2k8j6/plus__icon.jpg" alt="plus icon"></a>
            <a href="#"><img class="fa fa-minus collapse-isi expand-isi" src="https://awareness.tolsura.com/l/153741/2021-04-12/442dkx/153741/1618221206p3dCVT78/minus__icon.jpg" alt="minus icon"></a>
        </span>
        </p>
        <div class="warning-box">
            <p class="mb-0"><strong>BOXED WARNING</strong> <br /><strong>WARNING: CONGESTIVE HEART FAILURE and DRUG INTERACTIONS</strong> </p>
            <ul class="bullet1 mb-1 mt-1">
            <li> » CONGESTIVE HEART FAILURE</li>
            </ul>
            <p class="mb-1 pl-3"><strong>TOLSURA can cause or exacerbate congestive heart failure (CHF). When itraconazole was administered intravenously to healthy human volunteers and dogs, negative inotropic effects were seen. </strong>If signs or symptoms
            of congestive heart failure occur or worsen during administration of TOLSURA, reassess the benefit and risk of
            continuing treatment.</p>
            <ul class="bullet1">
                <li> » DRUG INTERACTIONS</li>
            </ul>
            <ul class="bullet2">
                <li>Co-administration of certain drugs that are metabolized by human CYP3A4 enzymes are contraindicated with
                    TOLSURA because plasma concentrations of such drugs are increased, which may also increase or prolong both the
                    pharmacologic effects and/or adverse reactions to these drugs.</li>
                <li>Co-administration with colchicine, fesoterodine and solifenacin is contraindicated in subjects with varying degrees of renal or hepatic impairment, and</li>
                <li>Co-administration with eligustat is contraindicated in subjects taking strong or moderate CYP2D6 inhibitors. </li>
                <li>Increased plasma concentrations of some of these drugs caused by co-administration with TOLSURA can lead to QT prolongation and/or ventricular tachyarrhythmias, including occurrences of torsades de pointes, a potentially fatal arrhythmia. </li>
            </ul>
        </div>
        <p class="mb-0"><strong>Indications and Usage</strong> </p>
        <p >TOLSURA is an azole antifungal indicated for the treatment of the following fungal infections in <strong>immunocompromised and non-immunocompromised</strong> adult patients:</p>           
        <ul class="bullet2 ml-2">
            <li>Blastomycosis, pulmonary and extrapulmonary</li>
            <li>Histoplasmosis, including chronic cavitary pulmonary disease and disseminated, non-meningeal histoplasmosis, and</li>
            <li>Aspergillosis, pulmonary and extrapulmonary, in patients who are intolerant of or who are refractory to amphotericin B therapy </li>
        </ul>
        <p class="mb-0 mb-2 mt-4"><strong>Limitations of Use:</strong></p>
            <p class="mb-0">TOLSURA is not indicated for the treatment of onychomycosis.</p>
            <p class="mb-0">TOLSURA is NOT interchangeable or substitutable with other itraconazole products.</p>
            <p class="mb-0 mb-2 mt-4"><strong>Contraindications</strong></p>
            <p class="mb-0">Co-administration with certain drugs that either affect metabolism of itraconazole or whose metabolism is affected by itraconazole Hypersensitivity to itraconazole</p>            
        <p class="mb-0 mb-2 mt-4"><strong>Warnings and Precautions</strong></p>
        <ul class="bullet2 ml-2">
            <li><strong>Hepatotoxicity:</strong> Serious hepatotoxicity, including liver failure and death, were reported with the use of itraconazole. Discontinue treatment if signs of liver dysfunction occur</li>
            <li><strong>Cardiac Dysrhythmias:</strong> Life-threatening cardiac dysrhythmias and/or sudden death have occurred in patients using certain drugs that are metabolized by human CYP450 enzymes concomitantly with oral itraconazole and/or other CYP3A4 inhibitors.</li>
            <li><strong>Peripheral Neuropathy:</strong> This has been reported in patients on long-term therapy with itraconazole. Monitor and promptly evaluate neurologic symptoms </li>
            <li><strong>Hearing loss:</strong> Reversible or permanent hearing loss has been reported in patients. Discontinue treatment if hearing loss occurs </li>
        </ul>
        <p class="mb-0 mb-2 mt-4"><strong>Adverse Reactions</strong></p>
        <p class="mb-4">Most common adverse reactions (incidence ≥ 1%) are nausea, rash, vomiting, edema, headache, diarrhea, fatigue, fever, pruritus, hypertension, abnormal hepatic function, abdominal pain, dizziness, hypokalemia, anorexia, malaise, decreased libido, somnolence, albuminuria, and impotence.</p>
        <p class="mb-4"><strong>To report SUSPECTED ADVERSE REACTIONS, contact Mayne Pharma at <a href="tel:+18448258500">1-844-825-8500</a> or the FDA at 1-800-FDA-1088 or <a target="_blank" href="https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program"><u>www.fda.gov/medwatch.</u></a></strong></p>
        <p class="mb-0"><strong>For more information, please see full <a class="underline" target="_blank" href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=306352d1-9d5a-49ad-b72d-893b99546861&audience=professional"><u>Prescribing Information and Patient Information Leaflet.</u> </a></strong></p>
    </div>
</div>
<!-- ISI BLOCK END -->

<!-- FOOTER START -->
<footer>
    <div class="container">
        <div class="row">
            <div class="col-lg-3">
                <a href="#" class="footer__logo mb-lg-0 mb-4">
                    <img src="assets/img/TOLSURA_DARK_LOGO.png" alt="Tolsura">
                </a>
            </div>
            <div class="col-lg-5">
                <div class="footer__links mb-lg-0 mb-4">
                    <ul>
                        <li><a href="#">HOME</a></li>
                        <li><a href="#">INFECTIONS OVERVIEW</a></li>
                        <li><a href="#">ABOUT TOLSURA</a></li>
                        <li><a href="#">BENEFITS OF TOLSURA</a></li>
                        <li><a href="#">SAFETY</a></li>
                        <li><a href="#">DOSING</a></li>
                        <li><a href="#">SAVINGS</a></li>
                    </ul>
                </div>
            </div>
            <div class="col-lg-4">
                <div class="customer__service mb-4">
                    Customer Service <div class="d-block"><a href="tel:+18003448661">+1 800 344 8661</a></div>
                </div>
                <div class="address mb-4">
                    1240 Sugg Parkway, Greenville, NC 27834
                </div>
                <div class="medical__info mb-lg-3 mb-4">
                    Medical Information & Adverse Drug Events Reporting
                </div>
                <div class="report">
                    To report a suspected adverse reaction from one of our products, please contact Mayne Pharma at <a href="tel:+18448258500">1-844-825-8500</a> or the FDA at <a href="tel:+1800FDA1088">1-800-FDA-1088</a> or <a href="http://www.fda.gov/medwatch" target="_blank" >www.fda.gov/medwatch</a>.
                </div>
            </div>
        </div>
        <div class="footer__bottom pt-150">
            <div class="row">
                <div class="col-12">
                    <div class="social__icon">
                        <ul>
                            <li><a href="#"><img src="assets/img/Icons_brand_twitter.svg" alt="Twitter"></a></li>
                            <li><a href="#"><img src="assets/img/Icons_brand_facebook.svg" alt="Facebook"></a></li>
                        </ul>
                    </div>
                </div>
                <div class="col-12">
                    <div class="footer__copyright">
                        <div class="row">
                            <div class="col-lg-6">
                                <div class="d-flex">
                                    <div class="copyright__text">© 2021 <a href="https://www.maynepharma.com/" target="_blank">Mayne Pharma</a>. All Rights Reserved.</div>
                                    <div class="pm__tool">PM-US-TOL-0002. 01/19</div>
                                </div>
                            </div>
                            <div class="col-lg-6">
                                <ul class="float-lg-right">
                                    <li><a href="https://www.maynepharma.com/privacy-policy/" target="_blank">Privacy Policy</a></li>
                                    <li><a href="https://www.maynepharma.com/terms-and-conditions/" target="_blank">Terms of Use</a></li>
                                </ul>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </div>
</footer>
<!-- FOOTER END -->


<!-- JS Script -->
<script src="assets/js/jquery-3.5.1.min.js"></script>
<script src="assets/js/bootstrap.min.js"></script>
<script src="assets/js/lazysizes.min.js"></script>
<script src="assets/js/ls.bgset.min.js"></script>
<script src="assets/js/custom.js"></script>
</body>
</html>
